Ancilia Biosciences
anciliabio.comLocations
New York, NY, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2019
Ancilia Biosciences develops engineered bacterial therapies to treat diseases linked to the microbiome. It provides and develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications.
Something looks off?Open jobs at Ancilia Biosciences
On-site & Remote
Salary